Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Probiotics Enhance the Treatment of PD-1 Inhibitors in Patients With Liver Cancer

NCT05032014 is registered in ClinicalTrials.gov with Jiangxi Provincial Cancer Hospital as lead sponsor.

NCT NCT05032014
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05032014 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Probiotics Enhance the Treatment of PD-1 Inhibitors in Patients With Liver Cancer
Lead sponsor
Jiangxi Provincial Cancer Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
November 19, 2021
Completion date
December 30, 2023
Enrollment
46 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer